All Pharma News
Mereo BioPharma and Cancer Focus Fund Announce Partnership for Phase 1b/2 Study of Etigilimab in Clear Cell Ovarian Cancer

Mereo BioPharma and Cancer Focus Fund Announce Partnership for Phase 1b/2 Study of Etigilimab in Clear Cell Ovarian Cancer
GLOBENEWSWIRE
30 Apr 2021
Share Share
Notice of AGM

Notice of AGM
PRESS RELEASE
16 Apr 2021
Share Share
Mereo to Present at 20th Annual Needham Virtual Healthcare Conference

Mereo to Present at 20th Annual Needham Virtual Healthcare Conference
PRESS RELEASE
06 Apr 2021
Share Share
Mereo to participate in SVB Leerink Healthcare Conference Fireside Chat

Mereo to participate in SVB Leerink Healthcare Conference Fireside Chat
PRESS RELEASE
18 Feb 2021
Share Share
Closing of Public Offering; Full Exercise of Over-Allotment Option

Closing of Public Offering; Full Exercise of Over-Allotment Option
PRESS RELEASE
12 Feb 2021
Share Share
Mereo BioPharma Group plc Announces Pricing of Public Offering of ADS

Mereo BioPharma Group plc Announces Pricing of Public Offering of ADS
PRESS RELEASE
10 Feb 2021
Share Share
Mereo BioPharma Group plc Announces Proposed Public Offering of ADS

Mereo BioPharma Group plc Announces Proposed Public Offering of ADS
PRESS RELEASE
09 Feb 2021
Share Share
Newly merged Mereo BioPharma looks to OncoMed for R&D hires

Newly merged Mereo BioPharma looks to OncoMed for R&D hires
Ben Adams FIERCE BIOTECH
30 Jun 2020
Share Share
Business Update and Directorate Change

Business Update and Directorate Change
BIOSPACE
26 Mar 2020
Share Share
Mereo BioPharma Receives FDA Fast Track Designation for Navicixizumab

Mereo BioPharma Receives FDA Fast Track Designation for Navicixizumab
YAHOO
07 Oct 2019
Share Share